CFG
AMRX icon

Citizens Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Citizens Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-493
Closed -$2K – 1074
2020
Q1 		$2K Hold
493
– – ﹤0.01% 989
2019
Q4 		$2K Buy
+493
New +$1.71K ﹤0.01% 950

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citizens Financial Group's AMRX Position: Q2 2020 in Review

Citizens Financial Group sold out of Amneal Pharmaceuticals (AMRX) in Q2 2020, closing a stake of 493 shares — an estimated $2K sold.

Citizens Financial Group first reported a position in AMRX in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 139 funds tracked by Wall St. Rank hold AMRX as of Q2 2020.

  • Citizens Financial Group reported no remaining Amneal Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Citizens Financial Group sold 493 Amneal Pharmaceuticals shares in Q2 2020, an estimated $2K.
  • Citizens Financial Group first reported a position in Amneal Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Citizens Financial Group's Amneal Pharmaceuticals position peaked at $2K in Q1 2020.
  • 139 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2020.

Based on Citizens Financial Group's 13F filing for Q2 2020, filed 12 Aug 2020.